{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:22:59Z","timestamp":1791559379318,"version":"4.3.4"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":257,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Psychiatry"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stevens\u2013Johnson syndrome (SJS) is a known, but rare adverse effect of Lamotrigine, occurring in less than 0.1% of the population. Rapid dose titrations of Lamotrigine, an antiepileptic used off\u2010label for the treatment of bipolar disorder, have been shown to increase the risk of SJS, and in even rarer cases, progression to toxic epidermal necrolysis (TEN), which currently has too few cases to report an estimated incidence. Data suggest that additional factors, including female sex and certain HLA alleles associated with East and Southeast Asian ancestries, may be associated with increased risk of Lamotrigine\u2010induced SJS\/TEN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This case presents a 26\u2010year\u2010old Southeast Asian female with bipolar I disorder who developed SJS shortly after her Lamotrigine dose was titrated appropriately from 50 milligrams (mg) to 100\u2009mg daily, which rapidly progressed to TEN. The patient received treatment, including steroids, intravenous (IV) immunoglobulin, and surgical debridement, and was discharged home in stable condition after 8 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case prompts consideration of sex and ancestry when identifying high\u2010risk populations taking Lamotrigine. Continued research into sex\u2010 and ancestry\u2010based pharmacogenomics may reduce the incidence of these life\u2010threatening reactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/crps\/2560198","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:35:11Z","timestamp":1789536911000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lamotrigine\u2010Associated Toxic Epidermal Necrolysis in a Southeast Asian Female: A Case Report Highlighting Sex and Ancestry\u2010Related Susceptibility"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8017-4483","authenticated-orcid":false,"given":"Sydney","family":"Christopherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6720-8121","authenticated-orcid":false,"given":"Naomi","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3240-6164","authenticated-orcid":false,"given":"Jonathan","family":"Wirjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"e_1_2_14_1_2","article-title":"Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study","volume":"110","author":"Glahn J. Z.","year":"2024","journal-title":"Seizure"},{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2023.06.014"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175070"},{"key":"e_1_2_14_4_2","volume-title":"StatPearls","author":"Betchel N. T.","year":"2023"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.64719\/pb.4398"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.06.024"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2015.01.016"},{"key":"e_1_2_14_8_2","unstructured":"U.S. Food and Drug Administration Lamictal (lamotrigine) Tablets Tablets for Oral Suspension and Orally Disintegrating Tablets: Prescribing Information 2025 GlaxoSmithKline Accessed November 11 2025https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/020241s066s067 020764s059s060 022251s030s031lbl.pdf."},{"key":"e_1_2_14_9_2","first-page":"27","article-title":"Rechallenge With Lamotrigine After a Rash: A Prospective Case Series and Review of the Literature","volume":"7","author":"Aiken C. B.","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2024.07.006"},{"key":"e_1_2_14_11_2","article-title":"HLA Class I Alleles Are Strongly Associated With Lamotrigine-Induced Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis in a US Population","volume":"65","author":"Ashraf M.","year":"2024","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00978-8"},{"key":"e_1_2_14_13_2","article-title":"Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17, and ABCB1 Polymorphisms on Lamotrigine Metabolism in Danish Patients","volume":"187","author":"Petrenaite V.","year":"2022","journal-title":"Epilepsy Research"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.70028"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bd8295"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000531"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004008"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2022.09.011"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.875283"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e26713"},{"key":"e_1_2_14_21_2","first-page":"87","article-title":"Pharmacogenomics of Antiseizure Medication-Induced Severe Cutaneous Adverse Reactions: Current Evidence and Future Perspectives","volume":"26","author":"Alvarado K.","year":"2025","journal-title":"Pharmacogenomics"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826aac73"},{"key":"e_1_2_14_23_2","first-page":"755","article-title":"Prevention of Severe Cutaneous Adverse Drug Reactions Through HLA-Guided Pharmacogenomic Testing","volume":"160","author":"Gu X.","year":"2024","journal-title":"Jama Dermatology"}],"container-title":["Case Reports in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crps\/2560198","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/crps\/2560198","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/crps\/2560198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:35:14Z","timestamp":1789536914000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/crps\/2560198"}},"subtitle":[],"editor":[{"given":"Nikhat","family":"Kaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/crps\/2560198"],"URL":"https:\/\/doi.org\/10.1155\/crps\/2560198","archive":["Portico"],"relation":{},"ISSN":["2090-682X","2090-6838"],"issn-type":[{"value":"2090-682X","type":"print"},{"value":"2090-6838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2560198"}}